Urologic Pathology News

VARIANTS OF UROTHELIAL CARCINOMA by Bahram Robert Oliai, M.D.
Although most of us are familiar with the features, behavior and treatment of the “usual” type urothelial (so-called transitional
cell) carcinoma

Read more...
 
VARIANTS OF PROSTATE CARCINOMA by Bahram Robert Oliai, M.D.
Although the overwhelming majority of prostate cancers are acinar adenocarcinomas, behaving in accordance to their various Gleason scores
Read more...
 
Print
Uro logo
Our division provides a comprehensive menu of superior pathology services to support your busy urology practice.

Our experience, diagnostic excellence, competitive turnaround time, outstanding customer service, and the personal interaction with our urologic pathologists, clearly distinguish us. In addition, the division works closely with ProPath’s internationally acclaimed Immunohistochemistry laboratory, allowing us to solve even the most difficult diagnostic dilemmas, in most cases within 24 hours of specimen receipt.


The director of the division, Bahram Robert Oliai M.D, is board certified in Cytopathology and Anatomic and Clinical Pathology. Before joining ProPath, Dr. Oliai spent two years in private practice in Chicago and did additional subspecialty training in Urologic Pathology on Dr. Jonathan Epstein’s consult service at The Johns Hopkins Hospital.

 

Cary J. Buresh, M.D.







Bahram R. Oliai, M.D.

Director, ProPath UroDiagnostics™